AI × Life Sciences · Building the infrastructure for traditional medicine.

AI × Life Sciences

Making traditional medicine legible to modern science.

Zhurong is an AI and life-sciences company. Two tracks, one evidence standard: clinical intelligence that makes every consultation verifiable, and AI-driven discovery that turns botanical medicine into characterised candidates.

Sliced astragalus root and reference material on a pale surface
Astragalus root, reference grade — characterised in our plant-science programme
Clinical intelligence Consent-based capture, structured records, differentiation support
Plant science & discovery Chemical characterisation, target prediction, candidate selection
Care network A collaboration platform for licensed practitioners, starting in the United States

Who we are

We are not a software company that happens to work in healthcare. We are a life-sciences company whose first instrument happens to be software.

Zhurong exists to answer a question that has been left open for a century: can a clinical tradition with two thousand years of accumulated observation be made legible — to regulators, to researchers, to the patients who need it — without being flattened into something it is not?

We work at the seam between two systems of knowledge. On one side, classical Chinese medicine: pattern differentiation, formula composition, a long record of observed outcomes. On the other, the instruments of modern life science: structured data, quality control, statistical evaluation and machine intelligence. Our work is to build the bridge — and then to hold both ends of it to the same standard.

Our first deployment is a clinical collaboration platform for licensed practitioners. It is a project, not the company.

Founded as
A life-sciences company, not a platform operator
Discipline
Clinical AI · botanical science · regulatory science
First market
Traditional Chinese medicine clinics in the United States
Research partner
Institute of Botany — a long-term collaboration

What we do

Three capabilities, built to depend on one another: the intelligence that reads a consultation, the plant science that makes a botanical trustworthy, and the network that carries both into a clinic.

A sunlit consultation desk with clinical notes, a laptop and dried chrysanthemum flowers
01

Clinical intelligence

Ambient clinical intelligence for a tradition that has never been fully written down.

With patient consent, a visit is recorded and transcribed in English, Mandarin or Cantonese, then resolved into a structured record: chief complaint, the ten questions, allergies, family history, each claim linked back to the sentence it came from. The system proposes candidate patterns and a formula draft. A deterministic safety engine blocks restricted constituents, allergens, pregnancy contraindications and known drug interactions before anything reaches a physician.

  • Clinical documentation
  • Pattern differentiation
  • Safety rules engine
  • Evaluation benchmarks
Sliced astragalus root specimen on ivory paper
02

Plant science & drug discovery

A formula is only as good as its raw material — and its raw material is only as good as the science behind it.

We treat herbs as pharmaceutical starting material, not as agricultural commodity. Species identity and origin are verified; every batch is tested for heavy metals, pesticides, microbial load and marker compounds; manufacturing runs only with cGMP partners registered with the FDA, and every batch is traceable from supplier to patient. Characterisation is also where discovery begins: fingerprints, constituent profiles and assay data feed models that rank formula-level combinations against target panels — so a classical formula becomes a testable candidate, not an anecdote.

  • Botanical identity
  • Chemical profiling
  • cGMP manufacturing
  • Target & pathway models
A diagram of connected clinics forming a care network
03

Care network

Nothing changes until it reaches the treatment room.

Our collaboration platform connects patients, licensed practitioners and qualified manufacturers into one continuous chain: appointment, record, consultation, formula recommendation, order, fulfilment and follow-up. Practitioners are verified against state licensure before they can see a single patient; products pass an admission review before they can appear in a single order. The first market is the roughly 23,000 TCM clinics across the United States.

  • Appointments & records
  • Practitioner workspace
  • Orders & fulfilment
  • Long-term follow-up

Research & partnership

We work in long-term partnership with the Institute of Botany — not as a supplier relationship, but as a shared laboratory. Their germplasm, reference standards and taxonomy; our models, data and clinical reach.

Plant science, treated as a computational discipline.

Herbarium specimen, microscope slide and reference standards on a research bench
  1. 01

    Chemical characterisation

    Fingerprint chromatography, multi-component quantification and batch-to-batch comparison, so a formula behaves in its fifth year the way it behaved in its first.

  2. 02

    Formula logic

    Combination patterns mined from classical formulas, institute records and de-identified clinical data — producing hypotheses a pharmacologist can test, not correlations a marketer can quote.

  3. 03

    Quality markers

    Markers chosen for biological relevance rather than analytical convenience, with rapid near-infrared screening that a receiving dock can actually run on every lot.

  4. 04

    Discovery

    Constituent libraries are screened against target panels; combination models rank formula-level synergy and flag likely mechanisms. The output is a short list a pharmacologist can test — and, in time, candidates that leave our pipeline for development partners.

  5. 05

    Bench to treatment room

    Germplasm and standards travel toward industry; structured, de-identified clinical outcomes travel back toward research. Both directions are governed by written agreements.

With the Institute of Botany

  • Shared germplasm, voucher specimens and reference standards
  • A joint formula, constituent and literature database
  • Co-designed studies, co-authored papers, real-world evidence

AI here is not a writing tool. It is the method that puts phytochemistry, pharmacology and twenty years of clinical notes on the same map.

Zhurong · research principle

Flagship initiative

From a conversation in a treatment room to a traceable product in a patient’s hands — with a licensed physician’s signature in the middle of it.

The TCM AI Collaboration Platform

  1. 01

    Consent & capture

    Recording begins only after both patient and physician consent. Multilingual transcription separates the two speakers.

  2. 02

    Structured record

    Symptoms, allergies and family history are extracted from the conversation and traced to their source sentence.

  3. 03

    Differentiation & draft

    Candidate patterns with supporting evidence, and a formula draft drawn only from admitted products.

  4. 04

    Safety verification

    Hard rules return block, warn or note. A block cannot be overridden by a physician’s convenience.

  5. 05

    Order, batch, follow-up

    Custom manufacture, batch release, tracked delivery, dosing reminders and return visits.

The human in the loop Physician review & electronic signature

AI produces drafts. A licensed practitioner reviews, edits and signs. Nothing takes effect before that signature.

  • AI drafts, the physician signs
  • Only admitted products can be ordered
  • Hard rules come before automation

Science & measurement

What we hold ourselves to.

In traditional medicine, “it works” has usually meant “it has been observed to work.” Our task is to make that observation measurable without losing its nuance.

Transcription error rateMeasured against human-corrected transcripts, reported separately by language and accent.
Extraction recallAllergies and family history must never be missed; scored on a hand-labelled evaluation set.
Draft revision rateHow much clinicians change our record drafts — lower means closer to clinical idiom.
Recommendation adoptionAccepted whole, edited, or rewritten; tracked separately, because the middle number is the honest one.
Safety-block coverageThe test set of known contraindications must pass in full, under versioned rules.
Return-visit rateThe share of patients who come back within the recommended interval.
Fulfilment timeOrder to signature, reported by product form.
Adverse-event reportingTime from identification to regulatory report. Zero missed serious events is the only acceptable target.

The framework we build inside

  • DSHEAProducts are dietary supplements; structure and function claims only.
  • cGMP · 21 CFR 111Manufacturing partners registered with the FDA, audited, with batch-level certificates of analysis.
  • HIPAA & BAAHealth information handled under business associate agreements, with encryption, access control and audit logs.
  • State licensurePractitioners verified in each state where they practise, with scope-of-practice rules configured per state.
  • Adverse eventsCollection, assessment and reporting procedures in place before the first order ships.

How we build

Phase 01

Clinical foundation

3–4 months

Licensure verification, product admission, appointments, patient records, orders and logistics.

Phase 02

Ambient documentation

3–4 months

Consent-based recording, multilingual transcription, structured records, and the safety engine going live.

Phase 03

Formula intelligence

4–6 months

Knowledge base and retrieval, differentiation references, practitioner-style adaptation, adoption measurement.

Phase 04

Scale & deepen

Ongoing

Real-time capture, tongue-image research, multi-state expansion, and real-world evidence with research partners.

People & partners

Clinicians, engineers and regulators, at the same table.

Clinical

Licensed TCM practitioners and pharmacy advisors own the knowledge base, the safety rules and the evaluation set.

AI & speech

Multilingual recognition, retrieval, evaluation design and model auditing — built to be replaced, not defended.

Quality & regulatory

FDA and DSHEA counsel, cGMP auditors, HIPAA and state-licensure specialists, involved from the first week.

Product & operations

Clinical product design, supply chain, fulfilment and patient service — the unglamorous half of safety.

  • Research institutes
  • cGMP manufacturers
  • FDA & healthcare counsel
  • Academic collaborators